Brief: Kaleido Biosciences Reports Second Quarter 2019 Financial Results And Provides Corporate Update

Kaleido Biosciences

01/08/2019 12:33

Aug 1 (Reuters) - Kaleido Biosciences Inc  KLDO.O :
    * KALEIDO BIOSCIENCES REPORTS SECOND QUARTER 2019 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * Q2 LOSS PER SHARE $0.83
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.71 -- REFINITIV IBES
DATA
    * DATA FROM A NON-IND CLINICAL STUDY OF KB174 IN HEALTHY
SUBJECTS
TO EXPLORE DOSING EXPECTED IN Q4 2019
    * DATA FROM A NON-IND CLINICAL STUDY OF KB174 IN PATIENTS
WITH
WELL-COMPENSATED CIRRHOSIS EXPECTED IN Q4 2019
    * CASH AND CASH EQUIVALENTS WERE $100.0 MILLION AS OF JUNE
30,
2019.

Source text for Eikon:  ID:nGNX3kJNYs 
Further company coverage:  KLDO.O 

 ((Reuters.Briefs@thomsonreuters.com;))